Press Release Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026 Aprea Therapeutics · Jul 30
Press Release Innventure to Announce Second Quarter 2026 Results on August 13, 2026 Innventure, Inc. · Jul 30
Press Release Heroes Better Positioned Than Many Americans to Achieve Homeownership, New Homes for Heroes Research Finds Homes for Heroes · Jul 30
Press Release VirTra Accepted for Inclusion in U.S. Army Marketplace for Three Mission-Critical Capability Areas VirTra, Inc. · Jul 30
Press Release Aureus Greenway Holdings Inc. and Autonomous Power Corporation (dba Powerus) Announce Public Filing of Form S-4 Registration Statement with the SEC Aureus Green Holdings Inc. · Jul 30
Press Release Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 Verrica Pharmaceuticals Inc. · Jul 30
Press Release RESCENE Earns First-Ever Music Show Win on THE SHOW “We Hope This Trophy Can Bring Hope to Everyone Chasing Their Dreams” BIGC · Jul 30
Press Release CereVasc Opens New Massachusetts Facility in Preparation for eShunt® System Commercialization CereVasc, Inc. · Jul 30
Press Release Brennan Investment Group Expands Midwest Portfolio with Acquisition of Industrial Facility in Dayton, Ohio Brennan Investment Group · Jul 30
Press Release Ensora Health Launches Ensai℠, One AI Across Five Therapy Disciplines Ensora Health · Jul 30
Press Release The Biological Computing Co. (TBC) Releases Proof of Concept for Neurally-Optimized AI Software The Biological Computing Co. · Jul 30